Skip to main content
Erschienen in: Endocrine 1/2015

01.05.2015 | Original Article

Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism

verfasst von: Ethem Turgay Cerit, Mujde Akturk, Alev E. Altinova, Yusuf Tavil, Cigdem Ozkan, Cagri Yayla, Mustafa Altay, Canan Demirtas, Nuri Cakir

Erschienen in: Endocrine | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to investigate body composition changes, epicardial adipose tissue thickness (EATT), serum omentin-1 levels, and the relationship among them along with some atherosclerosis markers in overt hypothyroidism. Twenty-eight newly diagnosed overt hypothyroid patients were evaluated before and after 6 months of thyroid hormone replacement therapy (THRT) and compared to the healthy subjects in this prospective longitudinal study. Body compositions were measured with dual-energy X-ray absorptiometry, and EATT was measured by echocardiography. Carotid intima-media thickness (c-IMT), flow-mediated dilatation (FMD), thyroid hormone levels, lipid parameters, high sensitive c-reactive protein, homocysteine, and omentin-1 levels were measured in all subjects. Body weight and lean body mass were higher in patients with hypothyroidism compared to euthyroid state after THRT (p = 0.012, 0.034, respectively). EATT was higher in patients with hypothyroidism than the control group (p < 0.001) and decreased with THRT (p = 0.012) but still remained higher than the control group (p < 0.001). Free T4 levels were found to be an independent factor to predict EATT (p < 0.001). In hypothyroid state, omentin-1 levels were lower than controls (p = 0.037) but increased in 6 months with THRT (p = 0.001). The c-IMT was higher, and FMD was lower in hypothyroidism compared to euthyroid state and control group (p < 0.05). Increasing lean body mass, but not adipose tissue mass, was found to be responsible for weight gain in hypothyroidism. The increased amount of EATT and decreased omentin-1 levels can contribute to the development of atherosclerosis in addition to other factors in hypothyroidism.
Literatur
1.
Zurück zum Zitat G. Huber, J.J. Staub, C. Meier, C. Mitrache, M. Guglielmetti, P. Huber, L.E. Braverman, Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab. 87(7), 3221–3226 (2002)CrossRefPubMed G. Huber, J.J. Staub, C. Meier, C. Mitrache, M. Guglielmetti, P. Huber, L.E. Braverman, Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab. 87(7), 3221–3226 (2002)CrossRefPubMed
2.
Zurück zum Zitat A.P. Weetman, A.M. McGregor, Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15(6), 788 (1994)PubMed A.P. Weetman, A.M. McGregor, Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15(6), 788 (1994)PubMed
3.
Zurück zum Zitat T. Tzotzas, G.E. Krassas, T. Konstantinidis, M. Bougoulia, Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10(9), 803–818 (2000)CrossRefPubMed T. Tzotzas, G.E. Krassas, T. Konstantinidis, M. Bougoulia, Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10(9), 803–818 (2000)CrossRefPubMed
4.
Zurück zum Zitat N. Knudsen, P. Laurberg, L.B. Rasmussen, I. Bulow, H. Perrild, L. Ovesen, T. Jorgensen, Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90, 4019–4024 (2005)CrossRefPubMed N. Knudsen, P. Laurberg, L.B. Rasmussen, I. Bulow, H. Perrild, L. Ovesen, T. Jorgensen, Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90, 4019–4024 (2005)CrossRefPubMed
5.
Zurück zum Zitat C.S. Fox, M.J. Pencina, R.B. D’Agostino, J.M. Murabito, E.W. Seely, E.N. Pearce, R.S. Vasan, Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch. Intern. Med. 168(6), 587–592 (2008)CrossRefPubMed C.S. Fox, M.J. Pencina, R.B. D’Agostino, J.M. Murabito, E.W. Seely, E.N. Pearce, R.S. Vasan, Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch. Intern. Med. 168(6), 587–592 (2008)CrossRefPubMed
6.
Zurück zum Zitat A. De Moura Souza, R. Sichieri, Association between serum TSH concentration within the normal range and adiposity. Eur. J. Endocrinol. 165(1), 11–15 (2011)CrossRefPubMed A. De Moura Souza, R. Sichieri, Association between serum TSH concentration within the normal range and adiposity. Eur. J. Endocrinol. 165(1), 11–15 (2011)CrossRefPubMed
7.
Zurück zum Zitat B.O. Asvold, T. Bjoro, L.J. Vatten, Association of serum TSH with high body mass differs between smokers and never-smokers. J. Clin. Endocrinol. Metab. 94(12), 5023–5027 (2009)CrossRefPubMed B.O. Asvold, T. Bjoro, L.J. Vatten, Association of serum TSH with high body mass differs between smokers and never-smokers. J. Clin. Endocrinol. Metab. 94(12), 5023–5027 (2009)CrossRefPubMed
8.
Zurück zum Zitat A. Svare, T.I. Nilsen, T. Bjoro, B.O. Asvold, A. Langhammer, Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin. Endocrinol. 74(6), 769–775 (2011)CrossRef A. Svare, T.I. Nilsen, T. Bjoro, B.O. Asvold, A. Langhammer, Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin. Endocrinol. 74(6), 769–775 (2011)CrossRef
9.
Zurück zum Zitat J. Westerink, Y. van der Graaf, D.R. Faber, F.L. Visseren, SMART study group, The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur. J. Clin. Invest. 41(2), 159–166 (2011)CrossRefPubMed J. Westerink, Y. van der Graaf, D.R. Faber, F.L. Visseren, SMART study group, The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur. J. Clin. Invest. 41(2), 159–166 (2011)CrossRefPubMed
10.
Zurück zum Zitat B.J. Hoogwerf, F.Q. Nuttall, Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am. J. Med. 76(6), 963–970 (1984)CrossRefPubMed B.J. Hoogwerf, F.Q. Nuttall, Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am. J. Med. 76(6), 963–970 (1984)CrossRefPubMed
11.
Zurück zum Zitat J. Karmisholt, S. Andersen, P. Laurberg, Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxedema. J. Clin. Endocrinol. Metab. 96, 99–103 (2011)CrossRef J. Karmisholt, S. Andersen, P. Laurberg, Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxedema. J. Clin. Endocrinol. Metab. 96, 99–103 (2011)CrossRef
12.
Zurück zum Zitat S. Gjedde, L.C. Gormsen, A.L. Riis, J.O. Jorgensen, J. Rungby, N. Moller, J. Weeke, S.B. Pedersen, Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 95, 3537–3541 (2010)CrossRefPubMed S. Gjedde, L.C. Gormsen, A.L. Riis, J.O. Jorgensen, J. Rungby, N. Moller, J. Weeke, S.B. Pedersen, Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 95, 3537–3541 (2010)CrossRefPubMed
13.
Zurück zum Zitat J. Brunova, P. Kasalicky, V. Lansk, The assessment of body composition using DXA in patients with thyroid dysfunction. Cas. Lek. Cesk. 146(5), 497–502 (2007)PubMed J. Brunova, P. Kasalicky, V. Lansk, The assessment of body composition using DXA in patients with thyroid dysfunction. Cas. Lek. Cesk. 146(5), 497–502 (2007)PubMed
14.
Zurück zum Zitat L. Portmann, V. Giusti, Obesity and hypothyroidism: myth or reality? Rev Med Suisse. 3(105), 859–862 (2007)PubMed L. Portmann, V. Giusti, Obesity and hypothyroidism: myth or reality? Rev Med Suisse. 3(105), 859–862 (2007)PubMed
15.
Zurück zum Zitat A.C. Silaghi, L. Poantă, A. Valea, R. Pais, H. Silaghi, Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason. 13(1), 15–20 (2011)PubMed A.C. Silaghi, L. Poantă, A. Valea, R. Pais, H. Silaghi, Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason. 13(1), 15–20 (2011)PubMed
16.
Zurück zum Zitat K. Ueno, T. Anzai, M. Jinzaki, M. Yamada, Y. Jo, Y. Maekawa, A. Kawamura, T. Yoshikawa, Y. Tanami, K. Sato, S. Kuribayashi, S. Ogawa, Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ. J. 73(10), 1927–1933 (2009)CrossRefPubMed K. Ueno, T. Anzai, M. Jinzaki, M. Yamada, Y. Jo, Y. Maekawa, A. Kawamura, T. Yoshikawa, Y. Tanami, K. Sato, S. Kuribayashi, S. Ogawa, Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ. J. 73(10), 1927–1933 (2009)CrossRefPubMed
17.
Zurück zum Zitat Y. Xu, X. Cheng, K. Hong, C. Huang, L. Wan, How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron. Artery Dis. 23(4), 227–233 (2012)CrossRefPubMed Y. Xu, X. Cheng, K. Hong, C. Huang, L. Wan, How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron. Artery Dis. 23(4), 227–233 (2012)CrossRefPubMed
18.
Zurück zum Zitat M. Asik, S. Sahin, F. Ozkul, I. Anaforoglu, S. Ayhan, S. Karagol, F. Gunes, E. Algun, Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin. Endocrinol. 79(4), 571–576 (2013)CrossRef M. Asik, S. Sahin, F. Ozkul, I. Anaforoglu, S. Ayhan, S. Karagol, F. Gunes, E. Algun, Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin. Endocrinol. 79(4), 571–576 (2013)CrossRef
19.
Zurück zum Zitat L. Korkmaz, S. Sahin, A.R. Akyuz, M. Ziyrek, I. Anaforoglu, M. Kose, H. Erkan, M.T. Agac, Z. Acar, Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med. Princ. Pract. 22(1), 42–46 (2013)CrossRefPubMed L. Korkmaz, S. Sahin, A.R. Akyuz, M. Ziyrek, I. Anaforoglu, M. Kose, H. Erkan, M.T. Agac, Z. Acar, Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med. Princ. Pract. 22(1), 42–46 (2013)CrossRefPubMed
20.
Zurück zum Zitat C.M. De Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, J.C. McLenithan, Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6), 1655–1661 (2007)CrossRefPubMed C.M. De Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, J.C. McLenithan, Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6), 1655–1661 (2007)CrossRefPubMed
21.
Zurück zum Zitat B.K. Tan, R. Adya, H.S. Randeva, Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc. Med. 20(5), 143–148 (2010)CrossRefPubMed B.K. Tan, R. Adya, H.S. Randeva, Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc. Med. 20(5), 143–148 (2010)CrossRefPubMed
22.
Zurück zum Zitat H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, K.W. Lee, M.S. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, K.M. Choi, S.H. Baik, Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. Endocrine 44(3), 680–687 (2013)CrossRefPubMed H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, K.W. Lee, M.S. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, K.M. Choi, S.H. Baik, Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. Endocrine 44(3), 680–687 (2013)CrossRefPubMed
23.
Zurück zum Zitat A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)CrossRefPubMed A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)CrossRefPubMed
24.
Zurück zum Zitat D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed
25.
Zurück zum Zitat G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11(2), 304–310 (2003)CrossRefPubMed G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11(2), 304–310 (2003)CrossRefPubMed
26.
Zurück zum Zitat G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)CrossRefPubMed G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)CrossRefPubMed
27.
Zurück zum Zitat N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)CrossRefPubMed N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)CrossRefPubMed
28.
Zurück zum Zitat M. Bauer, S. Caviezel, A. Teynor, R. Erbel, A.A. Mahabadi, A. Schmidt-Trucksäss, Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 142, w13705 (2012)PubMed M. Bauer, S. Caviezel, A. Teynor, R. Erbel, A.A. Mahabadi, A. Schmidt-Trucksäss, Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 142, w13705 (2012)PubMed
29.
Zurück zum Zitat G. Bartoli, G. Menegaz, M. Lisi, G. Di Stolfo, S. Dragoni, T. Gori, Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging. 2008, 738545 (2008)CrossRefPubMedCentralPubMed G. Bartoli, G. Menegaz, M. Lisi, G. Di Stolfo, S. Dragoni, T. Gori, Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging. 2008, 738545 (2008)CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat C.E. Flodmark, I. Lissau, L.A. Moreno, A. Pietrobelli, K. Widhalm, New insights into the field of children and adolescents’ obesity: the European perspective. Int. J. Obes. Relat. Metab. Disord. 28(10), 1189–1196 (2004)CrossRefPubMed C.E. Flodmark, I. Lissau, L.A. Moreno, A. Pietrobelli, K. Widhalm, New insights into the field of children and adolescents’ obesity: the European perspective. Int. J. Obes. Relat. Metab. Disord. 28(10), 1189–1196 (2004)CrossRefPubMed
31.
Zurück zum Zitat B.J. Strauss, P.R. Gibson, D.B. Stroud, D.J. Borovnicar, D.W. Xiong, J. Keogh, Total body dual X-ray absorbtiometry is a good measure of both fat mass and fat-free mass in liver cirrhosis compared to “gold-standard” techniques. Melbourne Liver Group. Ann. N. Y. Acad. Sci. 904, 55–62 (2000)CrossRefPubMed B.J. Strauss, P.R. Gibson, D.B. Stroud, D.J. Borovnicar, D.W. Xiong, J. Keogh, Total body dual X-ray absorbtiometry is a good measure of both fat mass and fat-free mass in liver cirrhosis compared to “gold-standard” techniques. Melbourne Liver Group. Ann. N. Y. Acad. Sci. 904, 55–62 (2000)CrossRefPubMed
32.
Zurück zum Zitat T. Miazgowski, B. Krzyżanowska-Świniarska, J. Dziwura-Ogonowska, K. Widecka, The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women. Endocrine (2014). doi:10.1007/s12020-014-0180-7 T. Miazgowski, B. Krzyżanowska-Świniarska, J. Dziwura-Ogonowska, K. Widecka, The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women. Endocrine (2014). doi:10.​1007/​s12020-014-0180-7
33.
Zurück zum Zitat T.J. Smith, R.S. Bahn, C.A. Gorman, Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr. Rev. 10, 366–391 (1989)CrossRefPubMed T.J. Smith, R.S. Bahn, C.A. Gorman, Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr. Rev. 10, 366–391 (1989)CrossRefPubMed
34.
Zurück zum Zitat F.W.F. Hanna, M.F. Scanlon, Hyponatraemia, hypothyroidism and role of arginine-vasopressin. Lancet 350, 755–756 (1997)CrossRefPubMed F.W.F. Hanna, M.F. Scanlon, Hyponatraemia, hypothyroidism and role of arginine-vasopressin. Lancet 350, 755–756 (1997)CrossRefPubMed
35.
Zurück zum Zitat H.S. Sacks, J.N. Fain, T.N. Memphis, Human epicardial adipose tissue: a review. Am. Heart J. 153, 907–917 (2007)CrossRefPubMed H.S. Sacks, J.N. Fain, T.N. Memphis, Human epicardial adipose tissue: a review. Am. Heart J. 153, 907–917 (2007)CrossRefPubMed
36.
Zurück zum Zitat H.S. Sacks, J.N. Fain, B. Holman, P. Cheema, A. Chary, F. Parks, J. Karas, R. Optican, S.W. Bahouth, E. Garrett, R.Y. Wolf, R.A. Carter, T. Robbins, D. Wolford, J. Samaha, Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J. Clin. Endocrinol. Metab. 94(9), 3611–3615 (2009)CrossRefPubMed H.S. Sacks, J.N. Fain, B. Holman, P. Cheema, A. Chary, F. Parks, J. Karas, R. Optican, S.W. Bahouth, E. Garrett, R.Y. Wolf, R.A. Carter, T. Robbins, D. Wolford, J. Samaha, Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J. Clin. Endocrinol. Metab. 94(9), 3611–3615 (2009)CrossRefPubMed
37.
Zurück zum Zitat G. Iacobellis, Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 46(1), 8–15 (2014)CrossRefPubMed G. Iacobellis, Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 46(1), 8–15 (2014)CrossRefPubMed
38.
Zurück zum Zitat G. Iacobellis, E. Lonn, A. Lamy, N. Singh, A.M. Sharma, Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int. J. Cardiol. 146(3), 452–454 (2011)CrossRefPubMed G. Iacobellis, E. Lonn, A. Lamy, N. Singh, A.M. Sharma, Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int. J. Cardiol. 146(3), 452–454 (2011)CrossRefPubMed
39.
Zurück zum Zitat G. Iacobellis, H.J. Willens, G. Barbaro, A.M. Sharma, Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity. 16(4), 887–892 (2008)CrossRefPubMed G. Iacobellis, H.J. Willens, G. Barbaro, A.M. Sharma, Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity. 16(4), 887–892 (2008)CrossRefPubMed
40.
Zurück zum Zitat T. Nagasaki, M. Inaba, Y. Henmi, Y. Kumeda, M. Ueda, H. Tahara, S. Sugiguchi, S. Fujiwara, M. Emoto, E. Ishimura, N. Onoda, T. Ishikawa, Y. Nishizawa, Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin. Endocrinol. 59(5), 607–612 (2003)CrossRef T. Nagasaki, M. Inaba, Y. Henmi, Y. Kumeda, M. Ueda, H. Tahara, S. Sugiguchi, S. Fujiwara, M. Emoto, E. Ishimura, N. Onoda, T. Ishikawa, Y. Nishizawa, Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin. Endocrinol. 59(5), 607–612 (2003)CrossRef
41.
Zurück zum Zitat F. Monzani, N. Caraccio, M. Kozàkowà, A. Dardano, F. Vittone, A. Virdis, S. Taddei, C. Palombo, E. Ferrannini, Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 89, 2099–2106 (2004)CrossRefPubMed F. Monzani, N. Caraccio, M. Kozàkowà, A. Dardano, F. Vittone, A. Virdis, S. Taddei, C. Palombo, E. Ferrannini, Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 89, 2099–2106 (2004)CrossRefPubMed
42.
Zurück zum Zitat J. Lekakis, C. Papamichael, M. Alevizaki, G. Piperingos, P. Marafelia, J. Mantzos, S. Stamatelopoulos, D.A. Koutras, Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 7(3), 411–414 (1997)CrossRefPubMed J. Lekakis, C. Papamichael, M. Alevizaki, G. Piperingos, P. Marafelia, J. Mantzos, S. Stamatelopoulos, D.A. Koutras, Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 7(3), 411–414 (1997)CrossRefPubMed
43.
Zurück zum Zitat M. Ito, T. Arishima, T. Kudo, E. Nishihara, H. Ohye, S. Kubota, S. Fukata, N. Amino, K. Kuma, I. Sasaki, T. Hiraiwa, T. Hanafusa, J. Takamatsu, A. Miyauchi, Effect of levothyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J. Clin. Endocrinol. Metab. 92, 608–611 (2007)CrossRefPubMed M. Ito, T. Arishima, T. Kudo, E. Nishihara, H. Ohye, S. Kubota, S. Fukata, N. Amino, K. Kuma, I. Sasaki, T. Hiraiwa, T. Hanafusa, J. Takamatsu, A. Miyauchi, Effect of levothyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J. Clin. Endocrinol. Metab. 92, 608–611 (2007)CrossRefPubMed
Metadaten
Titel
Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism
verfasst von
Ethem Turgay Cerit
Mujde Akturk
Alev E. Altinova
Yusuf Tavil
Cigdem Ozkan
Cagri Yayla
Mustafa Altay
Canan Demirtas
Nuri Cakir
Publikationsdatum
01.05.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0460-2

Weitere Artikel der Ausgabe 1/2015

Endocrine 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.